We are live on
!
Find out more
MMPW
Mitchell McLeod Pugh & Williams Portfolio holdings
AUM
$678M
1-Year Est. Return
23.02%
This Fund
S&P 500
This Quarter
Est. Return
+22.17%
1 Year Est. Return
+23.02%
3 Year Est. Return
+76.47%
5 Year Est. Return
+103.31%
10 Year Est. Return
+375.5%
AUM
$176M
AUM Growth
+$46.3M
(+36%)
Cap. Flow
+$20.8M
Cap. Flow
% of AUM
11.84%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
190
New
24
Increased
90
Reduced
23
Closed
4
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
+$2.07M |
| 2 |
Visa
V
|
+$975K |
| 3 |
Apple
AAPL
|
+$939K |
| 4 |
Vanguard Value ETF
VTV
|
+$907K |
| 5 |
Lockheed Martin
LMT
|
+$783K |
Top Sells
| 1 |
AGN
Allergan Inc
AGN
|
+$705K |
| 2 |
RTN
Raytheon Company
RTN
|
+$302K |
| 3 |
Weyerhaeuser
WY
|
+$238K |
| 4 |
Biogen
BIIB
|
+$207K |
| 5 |
Citigroup
C
|
+$204K |
Sector Composition
| 1 | Technology | 22.87% |
| 2 | Healthcare | 12.73% |
| 3 | Financials | 11.51% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Consumer Staples | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Fresenius Medical Care
FMS
$13B
| $209K | 0.12% |
+4,830
| New | +$191K |
|
177
GSK
GSK
$104B
| $203K | 0.12% |
+3,976
| New | +$204K |
|
178
Okta
OKTA
$26B
| $200K | 0.11% |
+1,000
| New | +$170K |
|
179
HP
HPQ
$22.7B
| $179K | 0.1% |
10,270
| – | – |
|
|
PRA
180
DELISTED
ProAssurance
PRA
| $172K | 0.1% |
11,862
| – | – |
|
181
Carnival Corporation Ltd
CCL
$36.2B
| $165K | 0.09% |
+10,030
| New | +$150K |
|
182
SiriusXM
SIRI
$10.3B
| $144K | 0.08% |
2,447
| – | – |
|
|
AMCR
183
DELISTED
AMCOR LTD ADR
AMCR
| $124K | 0.07% |
12,096
-590
| -5% | -$6.05K |
|
|
AMRN
184
Amarin Corp
AMRN
$292M
| $117K | 0.07% |
849
+286
| +51% | +$39.3K |
|
|
GRCE
185
Grace Therapeutics
GRCE
$40.2M
| $21K | 0.01% |
938
| – | – |
|
|
186
Biogen
BIIB
$30.4B
| – | – |
-655
| Closed | -$207K |
|
|
187
Weyerhaeuser
WY
$17.7B
| – | – |
-14,069
| Closed | -$238K |
|
|
RTN
188
DELISTED
Raytheon Company
RTN
| – | – |
-2,299
| Closed | -$302K |
|
|
AGN
189
DELISTED
Allergan Inc
AGN
| – | – |
-3,982
| Closed | -$705K |
|
Similar funds
TWM
DLIC
LTI
AVM
NI
REAM
MCO
SPA
Mitchell McLeod Pugh & Williams's Q2 2020 Portfolio in Review
As of Q2 2020, Mitchell McLeod Pugh & Williams held 190 positions worth $176M, up 36% from $130M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mitchell McLeod Pugh & Williams deployed $20.8M of net new capital in Q2 2020, opening 24 new positions and adding to 90 existing holdings. Its largest new stake was Lockheed Martin: 2,072 shares worth $756K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Citigroup, an estimated $204K trimmed.
- Mitchell McLeod Pugh & Williams's largest Q2 2020 buy was Lockheed Martin: 2,072 shares worth $756K.
- Mitchell McLeod Pugh & Williams added most to Vanguard Growth ETF in Q2 2020, an estimated $2.07M increase.
- Mitchell McLeod Pugh & Williams's biggest Q2 2020 reduction was Citigroup, cutting an estimated $204K.
- Mitchell McLeod Pugh & Williams fully exited Allergan Inc in Q2 2020, selling an estimated $705K.
- Mitchell McLeod Pugh & Williams's ten largest holdings make up 27% of its $176M portfolio in Q2 2020.
- Mitchell McLeod Pugh & Williams opened 24 new positions and closed 4 in Q2 2020.
- Mitchell McLeod Pugh & Williams's portfolio value rose 36% quarter-over-quarter to $176M.
Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2020, filed 17 Jul 2020.